See the European Union has spent hundreds of millions of euros in advance even before approval from the European Medicines Agency so that a vaccine can be produced so the moment it is approved it is there to be vaccinators so but thats also part of the problem astras is supplying vaccine to the United Kingdom isnt it. Exactly and the argument of the European Commission is that stress anika is a close call company that is producing not only in the e. U. But also in the u. K. Also in india and that supply chain problems must then affect all those countries that are buying vaccines and europe is the biggest customer and it cant be that its just europe that is carrying the burden just because the supply chain problem appears to be in a belgian factory but both are strong and the e. U. Have said its states in the contract that they respectively were right and now the redacted version of the contract that you have in front of you still doesnt shed any light on the core issues here why do you